Streptococcal growth and toxin production in vivo - PubMed (original) (raw)

Streptococcal growth and toxin production in vivo

J L Duncan. Infect Immun. 1983 May.

Abstract

Streptococcal growth in vivo was studied with inoculated micropore filter chambers which were implanted into the peritoneal cavities of mice. Eight of nine group A strains and one group B strain grew in vivo, achieving concentrations of 10(7) to 10(9) CFU/ml in the chambers. Experiments with the Richards strain showed that the number of viable organisms remained high at 5 and 8 weeks after infection. The use of specific inhibitors and appropriate toxin-negative strains demonstrated that both cytolytic toxins produced by group A streptococci, streptolysin S and streptolysin O, were present in the culture fluids harvested from the chambers. This finding represents the first evidence that streptolysin S is produced in vivo. The host response to streptococci growing in vivo was examined by following the increase in serum antistreptolysin O levels. The response was first detected 2 weeks after chamber implantation and appeared to be maximal after 5 weeks. In addition, the production of antibody to streptococcal cell surface antigens was demonstrated indirectly with fluorescein-labeled anti-mouse immunoglobulin G.

PubMed Disclaimer

References

    1. Nature. 1970 Aug 15;227(5259):680-5 -PubMed
    1. Science. 1958 Jun 6;127(3310):1337 -PubMed
    1. Zentralbl Bakteriol Mikrobiol Hyg A. 1982 Jul;252(3):287-98 -PubMed
    1. Pharmacol Ther. 1980;11(3):661-717 -PubMed
    1. J Med Microbiol. 1975 May;8(2):325-35 -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources